About this FactMed analysis covering adverse side effect reports of AIRBORNE patients who developed HYPERKERATOSIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking AIRBORNE reported HYPERKERATOSIS to the FDA. A total of 20 AIRBORNE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AIRBORNE and HYPERKERATOSIS. In doing so, we compare AIRBORNE with other drugs that cause HYPERKERATOSIS, to help you evaluate whether or not AIRBORNE causes HYPERKERATOSIS. Likewise, this page shows the most highly-reported side effects of AIRBORNE, so you can see if HYPERKERATOSIS ranks among AIRBORNE's most well-known side effects.
Summary Statistics
Reports of AIRBORNE causing HYPERKERATOSIS: 1
Reports of any side effect of AIRBORNE : 20
Percentage of AIRBORNE patients where HYPERKERATOSIS is a reported side effect: 5.0000%

FDA reports of any drug causing HYPERKERATOSIS : 1939
Average percentage for all medicated patients where HYPERKERATOSIS is reported as a complication: 0.0122%

Physician opinion on AIRBORNE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AIRBORNE:
MEDICAL DIET ( 3 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1 patients )
NASOPHARYNGITIS ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPERKERATOSIS:

FOSAMAX (842 patients)
ZOMETA (349 patients)
NEXAVAR (277 patients)
ASPIRIN (237 patients)
VIOXX (232 patients)
MAGNEVIST (211 patients)
EPOGEN (182 patients)
PREDNISONE (174 patients)
AREDIA (171 patients)
FOSAMAX PLUS D (155 patients)
HYDROCHLOROTHIAZIDE (153 patients)
OMNISCAN (153 patients)
LASIX (149 patients)
ZOCOR (146 patients)
COUMADIN (141 patients)
NEXIUM (136 patients)
NEURONTIN (134 patients)
PROTONIX (130 patients)
LIPITOR (128 patients)
VICODIN (127 patients)
PRILOSEC (122 patients)
MORPHINE (119 patients)
CALCIUM (118 patients)
LEVAQUIN (115 patients)
FOLIC ACID (114 patients)
HUMIRA (111 patients)
CELEXA (109 patients)
PAXIL (107 patients)
XANAX (103 patients)
SYNTHROID (102 patients)
ACIPHEX (102 patients)
AMBIEN (98 patients)
ACCUTANE (97 patients)
ALBUTEROL (97 patients)
ENBREL (97 patients)
LISINOPRIL (95 patients)
CYMBALTA (95 patients)
METHOTREXATE (95 patients)
PREVACID (93 patients)
NORVASC (92 patients)
OMEPRAZOLE (91 patients)
SUTENT (89 patients)
CELEBREX (87 patients)
PERCOCET (84 patients)
ELAVIL (84 patients)
REMICADE (82 patients)
EFFEXOR (82 patients)
PREMARIN (81 patients)
LEXAPRO (81 patients)
CALCIUM CARBONATE (81 patients)
OXYCONTIN (81 patients)
VITAMIN D (80 patients)
BONIVA (80 patients)
GABAPENTIN (80 patients)
ARANESP (80 patients)
INSULIN (79 patients)
ATIVAN (76 patients)
PREDNISOLONE (76 patients)
VITAMIN E (75 patients)
ACTONEL (74 patients)
SEROQUEL (74 patients)
IRON (74 patients)
ADVAIR DISKUS 100/50 (72 patients)
DEXAMETHASONE (72 patients)
CHLORHEXIDINE GLUCONATE (72 patients)
FLONASE (72 patients)
TOPROL-XL (71 patients)
AMOXICILLIN (71 patients)
AVELOX (71 patients)
ATENOLOL (71 patients)
DILAUDID (70 patients)
COREG (70 patients)
PROZAC (69 patients)
ZITHROMAX (68 patients)
RENAGEL (68 patients)
ZOFRAN (67 patients)
LORTAB (66 patients)
ALENDRONATE SODIUM (66 patients)
MULTI-VITAMINS (65 patients)
LEVOTHYROXINE SODIUM (65 patients)
COZAAR (64 patients)
FUROSEMIDE (64 patients)
OPTIMARK (64 patients)
REVLIMID (62 patients)
ALLOPURINOL (61 patients)
KLOR-CON (61 patients)
SPIRONOLACTONE (61 patients)
IBUPROFEN (60 patients)
SINGULAIR (60 patients)
TAMOXIFEN CITRATE (60 patients)
FASLODEX (59 patients)
TOPRAL (57 patients)
SIMVASTATIN (57 patients)
ASCORBIC ACID (57 patients)
ALPRAZOLAM (56 patients)
LYRICA (56 patients)
COMPAZINE (55 patients)
CHEMOTHERAPEUTICS NOS (55 patients)
DECADRON (55 patients)
AROMASIN (55 patients)
ASTELIN (54 patients)
CRESTOR (53 patients)
PENICILLIN ^GRUNENTHAL^ (53 patients)
[THERAPY UNSPECIFIED] (52 patients)
TAXOTERE (52 patients)
CYCLOSPORINE (52 patients)
ZOLOFT (51 patients)
RADIATION THERAPY (50 patients)
PREDNISONE TAB (50 patients)
GLUCOSAMINE (49 patients)
METRONIDAZOLE (48 patients)
DIOVAN (47 patients)
DOXYCYCLINE (46 patients)
ACETAMINOPHEN (45 patients)
CYTOXAN (45 patients)
CENTRUM (45 patients)
VITAMIN D (UNSPECIFIED) (44 patients)
CIPROFLOXACIN (44 patients)
PERIDEX (44 patients)
ARIMIDEX (44 patients)
PEPCID (44 patients)
WELLBUTRIN (44 patients)
RISPERDAL (43 patients)
BEXTRA (43 patients)
UNSPECIFIED GADOLINIUM-BASED CONTRAST AGENT (43 patients)
CITALOPRAM HYDROBROMIDE (43 patients)
TAXOL (43 patients)
CLONAZEPAM (43 patients)
CIPRO (43 patients)
BENADRYL ^ACHE^ (43 patients)
REQUIP (42 patients)
OXYCODONE HCL (42 patients)
PHOSLO (42 patients)
GADOLINIUM IN UNSPECIFIED DRUG (42 patients)
POTASSIUM CHLORIDE (42 patients)
LORAZEPAM (41 patients)
PROHANCE (40 patients)
CYTOMEL (40 patients)
BACTRIM (40 patients)
PLAVIX (40 patients)
ACYCLOVIR (39 patients)
FERROUS SULFATE TAB (39 patients)
FENTANYL (39 patients)
HUMALOG (39 patients)
COLACE (38 patients)
DEPAKOTE (38 patients)
LOVENOX (38 patients)
VELCADE (37 patients)
ALDACTONE (37 patients)
MULTIHANCE (37 patients)
NEUPOGEN (37 patients)
NAPROXEN (37 patients)
NEORAL (37 patients)
MORPHINE SULFATE (37 patients)
GLIPIZIDE (36 patients)
ACTOS (36 patients)
ZYPREXA (36 patients)
METOCLOPRAMIDE (36 patients)
FORTEO (36 patients)
FLUCONAZOLE (36 patients)
AUGMENTIN '125' (36 patients)
PROVIGIL (36 patients)
MACROBID (35 patients)
GLEEVEC (35 patients)
CALCIUM (UNSPECIFIED) (35 patients)
CELLCEPT (35 patients)
KENALOG (35 patients)
ALLEGRA (35 patients)
NYSTATIN (35 patients)
KEFLEX (35 patients)
CARTIA /USA/ (34 patients)
ULTRAM (34 patients)
PROTEINASE INHIBITORS (34 patients)
METOPROLOL TARTRATE (34 patients)
CALTRATE +D (34 patients)
METHADONE (34 patients)
KYTRIL (34 patients)
ROBAXIN (33 patients)
BYETTA (33 patients)
CLARITIN (33 patients)
CLONIDINE (33 patients)
ZETIA (33 patients)
B12 ^RECIP^ (33 patients)
HERCEPTIN (33 patients)
DARVOCET-N 100 (32 patients)
LORATADINE (32 patients)
VITAMIN B-12 (32 patients)
AMITRIPTYLINE HCL (32 patients)
HYTRIN (32 patients)
MAGNESIUM (32 patients)
VAGIFEM (32 patients)
VASOTEC (32 patients)
CLINDAMYCIN (32 patients)
FEMARA (31 patients)
ELMIRON (31 patients)
TRIAMTERENE (31 patients)
WARFARIN SODIUM (31 patients)
CENTRUM SILVER (31 patients)
TIAZAC (31 patients)
K-DUR (31 patients)
TRIAMCINOLONE (31 patients)
MOBIC (31 patients)
PERIOGARD (31 patients)
CYCLOPHOSPHAMIDE (30 patients)
EVOXAC (30 patients)
MS CONTIN (30 patients)
TERAZOSIN HCL (30 patients)
UNSPECIFIED GADOLINIUM CONTRAST (30 patients)
LIMBREL (30 patients)
MIRTAZAPINE (30 patients)
Most common side effects for patients taking AIRBORNE:
ALOPECIA (4 patients)
CONFUSIONAL STATE (4 patients)
AGEUSIA (3 patients)
ARTHRALGIA (3 patients)
LIGAMENT OPERATION (3 patients)
INFLUENZA (3 patients)
DRUG EFFECT DECREASED (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (2 patients)
VISION BLURRED (2 patients)
RESTLESSNESS (2 patients)
NASOPHARYNGITIS (2 patients)
MULTIPLE MYELOMA (2 patients)
CEREBROVASCULAR ACCIDENT (2 patients)
COORDINATION ABNORMAL (2 patients)
DRUG INEFFECTIVE (2 patients)
HYPOAESTHESIA (2 patients)
EPISTAXIS (2 patients)
DYSGRAPHIA (2 patients)
DYSARTHRIA (2 patients)
DRY SKIN (1 patients)
DYSPHEMIA (1 patients)
ECZEMA WEEPING (1 patients)
DRY MOUTH (1 patients)
ERYTHEMA (1 patients)
FATIGUE (1 patients)
FEELING ABNORMAL (1 patients)
GENITAL PAIN (1 patients)
HEADACHE (1 patients)
HEARING IMPAIRED (1 patients)
HEART RATE DECREASED (1 patients)
HYPERKERATOSIS (1 patients)
DRY EYE (1 patients)
HYPOREFLEXIA (1 patients)
CONSTIPATION (1 patients)
INJECTION SITE ERYTHEMA (1 patients)
INJECTION SITE IRRITATION (1 patients)
INJECTION SITE SWELLING (1 patients)
INSOMNIA (1 patients)
INTERNATIONAL NORMALISED RATIO ABNORMAL (1 patients)
LEARNING DISORDER (1 patients)
CONDITION AGGRAVATED (1 patients)
LIP SWELLING (1 patients)
LOCALISED INFECTION (1 patients)
LUNG NEOPLASM MALIGNANT (1 patients)
MEMORY IMPAIRMENT (1 patients)
APHASIA (1 patients)
ANXIETY (1 patients)
NAUSEA (1 patients)
NEOPLASM MALIGNANT (1 patients)
PRURITUS (1 patients)
PYREXIA (1 patients)
RASH (1 patients)
AMNESIA (1 patients)
RHINORRHOEA (1 patients)
SOMNOLENCE (1 patients)
SYNCOPE (1 patients)
URTICARIA (1 patients)
ACUTE SINUSITIS (1 patients)
WEIGHT INCREASED (1 patients)
WITHDRAWAL SYNDROME (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AIRBORNE


Issue Description / Topic Timestamp
CONCERN
DRY MOUTH
Took last night have severe dry mouth 2015-11-18 06:01:39
QUESTION
INSOMNIA
I take Amitryptyline and Trazodone. When I use Airborne I cannot get to sleep. 2017-10-07 15:22:45

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPERKERATOSIS and AIRBORNE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AIRBORNE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AIRBORNE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AIRBORNE experts. If you are a healthcare provider experienced in prescribing AIRBORNE, please register here.
giCould not connect: